Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters.

ABSTRACT:

Background

Obesity affects quality of life and life expectancy and is associated with cardiovascular disorders, cancer, diabetes, reproductive disorders in women, prostate diseases in men, and congenital anomalies in children. The use of single nucleotide polymorphism (SNP) markers of diseases and drug responses (i.e., significant differences of personal genomes of patients from the reference human genome) can help physicians to improve treatment. Clinical research can validate SNP markers via genotyping of patients and demonstration that SNP alleles are significantly more frequent in patients than in healthy people. The search for biomedical SNP markers of interest can be accelerated by computer-based analysis of hundreds of millions of SNPs in the 1000 Genomes project because of

SUBMITTER: Arkova OV 

PROVIDER: S-EPMC4686794 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature